This narrative review summarises the evidence for considering physical exercise (PE) as a
non-pharmacological intervention for delaying cognitive decline in patients with Alzheimer's …

Alzheimer's disease (AD) is a very disabling disease. Pathologically, it is characterized by
the presence of amyloid plaques and neurofibrillary tangles in the brain that results in …

Alzheimer's disease (AD) is a progressive disorder that causes brain cells to slowly
degenerate and die. This leads to a continuous decline in thinking, behavioral and social …

Abstract Alzheimer's disease (AD), a progressive, neurodegenerative condition
characterised by accumulation of toxic βeta-amyloid (Aβ) plaques, is one of the leading …

Alzheimer's disease (AD) is the most common form of dementia. With an aging population
and no disease modifying treatments available, AD is quickly becoming a global pandemic …

Alzheimer disease (AD) is a primary cause of cognitive dysfunction in the elderly population
worldwide. Despite the allocation of enormous amounts of funding and resources to …

Background: Alzheimer's disease (AD) is characterized by neuronal degeneration, vascular
pathology and cognitive decline. Furthermore, deficits in cerebral glucose metabolism and …

Alzheimer's disease (AD) is a progressive degenerative disorder and a leading cause of
dementia in the elderly. The etiology of AD is multifactorial, including an increased oxidative …

Objective Neuropsychiatric symptoms (NPs) affect almost all patients with Alzheimer disease
(AD). Because of the complications associated with the pharmacological treatment …

This narrative review aimed to summarize evidence regarding the responses to exercise
among patients with preclinical Alzheimer's disease (AD) and the effectiveness of long-term …